This resolution acknowledges the severe global impact of pediatric HIV/AIDS, noting that 1.4 million children were living with HIV in 2024 and that AIDS remains a leading cause of death among adolescent girls. It highlights that mother-to-child transmission can be significantly reduced with antiretroviral prophylaxis, yet progress in treatment for children lags behind adults. The text underscores the disproportionate burden on women and children, particularly in Sub-Saharan Africa, where a majority of new pediatric infections occur. To address this crisis, the resolution calls for continued **United States leadership** in the global AIDS response, building on programs like PEPFAR. It supports providing adolescents and women with **evidence-based approaches** to prevent new infections, including counseling, testing, and access to new long-acting prevention methods. Furthermore, it advocates for scaling up **age-appropriate treatment** for children and adolescents, aligning with the four pillars of the Global Alliance to End AIDS in Children by 2030, which include closing treatment gaps, preventing new infections, optimizing care for infants and children, and addressing social barriers. The resolution encourages PEPFAR to develop a **standalone pediatric HIV strategy** to eliminate new pediatric HIV infections worldwide.